BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16598528)

  • 1. Implementation of evidence-based therapy in patients with systolic heart failure from 1998-2000.
    Reibis R; Dovifat C; Dissmann R; Ehrlich B; Schulz S; Stolze K; Wegscheider K; Völler H
    Clin Res Cardiol; 2006 Mar; 95(3):154-61. PubMed ID: 16598528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of guideline adherence on mortality in treatment of left heart failure].
    Neubauer S; Schilling T; Zeidler J; Lange A; Engel S; Linder R; Verheyen F; von der Schulenburg JG; Haverich A
    Herz; 2016 Nov; 41(7):614-624. PubMed ID: 26883900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure.
    Juillière Y; Suty-Selton C; Riant E; Darracq JP; Dellinger A; Labarre JP; Druelle J; Mulak G; Danchin N; Jourdain P;
    Arch Cardiovasc Dis; 2014 Jan; 107(1):21-32. PubMed ID: 24388162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of drug adherence and medical care on heart failure outcome in the primary care setting in Austria.
    Marzluf BA; Reichardt B; Neuhofer LM; Kogler B; Wolzt M
    Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):722-30. PubMed ID: 25980789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adherence to guidelines in CHF therapy in Germany].
    Flesch M; Komajda M; Lapuerta P; Hermans N; Le Pen C; Gonzáles-Juanatey JR; Van Veldhuisen DJ; Tavazzi L; Poole-Wilson P; Erdmann E
    Dtsch Med Wochenschr; 2005 Sep; 130(39):2191-7. PubMed ID: 16189755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin prescribing for heart failure in elderly residents of long-term care facilities.
    Misiaszek B; Heckman GA; Merali F; Turpie ID; Patterson CJ; Flett N; McKelvie RS
    Can J Cardiol; 2005 Mar; 21(3):281-6. PubMed ID: 15776118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures.
    Allen LA; Fonarow GC; Liang L; Schulte PJ; Masoudi FA; Rumsfeld JS; Ho PM; Eapen ZJ; Hernandez AF; Heidenreich PA; Bhatt DL; Peterson ED; Krumholz HM;
    Circulation; 2015 Oct; 132(14):1347-53. PubMed ID: 26316616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
    Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D
    J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure.
    Curtis LH; Mi X; Qualls LG; Check DK; Hammill BG; Hammill SC; Heidenreich PA; Masoudi FA; Setoguchi S; Hernandez AF; Fonarow GC
    Am Heart J; 2013 Jun; 165(6):979-986.e1. PubMed ID: 23708170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary prevention of coronary artery disease in contemporary clinical practice.
    Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
    Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT.
    Skali H; Dwyer EM; Goldstein R; Haigney M; Krone R; Kukin M; Lichstein E; McNitt S; Moss AJ; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2014 May; 16(5):560-5. PubMed ID: 24578164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey on compliance with secondary stroke prevention guidelines and follow up for the inpatients with atherosclerotic cerebral infarction/transient ischemic attack.
    Ma R; Wang C; Zhao X; Xu M; Lv Y; Wei M; Cai Y; Zhang Z; Wang L; Zhang W; Huang Y; Li Y; Li H; Wang Y
    Neurol Res; 2008 May; 30(4):383-8. PubMed ID: 18544256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).
    Albert NM; Fonarow GC; Yancy CW; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride M; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am Heart J; 2010 Feb; 159(2):238-44. PubMed ID: 20152222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimal pharmacotherapy according to guideline improved prognosis of outpatients with chronic heart failure].
    Duan HY; Wu XS; Han ZH; Guo YF; Fang SJ; Zhang XX; Wang CM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):26-9. PubMed ID: 21418792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial).
    O'Connor CM; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; McBride ML; Inge PJ; Mehra MR; Reynolds D; Walsh MN; Yancy CW; Fonarow GC
    Am J Cardiol; 2011 Jan; 107(2):250-8. PubMed ID: 21211602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guideline conformity and outcome of inpatient treatment for schizophrenia. A clinical comparison].
    Janssen B; Weinmann S; Berger M; Härter M; Held T; Leipert M; Luderer HJ; Schwarz M; Steinert T; Gaebel W
    Nervenarzt; 2005 Mar; 76(3):315-26. PubMed ID: 15759161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug therapy of coronary heart disease--are therapeutic guidelines being paid attention to?].
    Böger GI; Hoopmann M; Busse R; Budinger M; Welte T; Böger RH
    Z Kardiol; 2003 Jun; 92(6):466-75. PubMed ID: 12819995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is quality improvement sustainable? Findings of the American College of Cardiology's Guidelines Applied in Practice.
    Olomu AB; Stommel M; Holmes-Rovner MM; Prieto AR; Corser WD; Gourineni V; Eagle KA
    Int J Qual Health Care; 2014 Jun; 26(3):215-22. PubMed ID: 24815063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am J Cardiol; 2010 Apr; 105(8):1140-6. PubMed ID: 20381667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure medications prescribed at discharge for patients with left ventricular assist devices.
    Shreibati JB; Sheng S; Fonarow GC; DeVore AD; Yancy CW; Bhatt DL; Schulte P; Peterson ED; Hernandez A; Heidenreich PA
    Am Heart J; 2016 Sep; 179():99-106. PubMed ID: 27595684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.